Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review

被引：0
|
作者：
Damien Prouzeau
Ismaël Conejero
Peter L. Voyvodic
Carine Becamel
Mocrane Abbar
Jorge Lopez-Castroman
机构：
[1] Adult Psychiatry Department of Nîmes University Hospital,Centre de Biochimie Structurale (CBS), UMR 5048
[2] University of Montpellier,Institut de Génomique Fonctionnelle, UMR 5203
[3] INSERM U1054,CIBERSAM
[4] CNRS,undefined
[5] University of Montpellier,undefined
[6] INSERM U1191,undefined
[7] CNRS,undefined
[8] ISCIII,undefined
来源：
Current Psychiatry Reports | 2022年 / 24卷
关键词：
Hallucinogen; 5-HT2A agonists; Psychedelic; Mood disorder; Neuroimaging; Narrative review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：573 / 581
页数：8
相关论文
共 50 条
  • [1] Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review
    Prouzeau, Damien
    Conejero, Ismael
    Voyvodic, Peter L.
    Becamel, Carine
    Abbar, Mocrane
    Lopez-Castroman, Jorge
    [J]. CURRENT PSYCHIATRY REPORTS, 2022, 24 (10) : 573 - 581
  • [2] Treatments and their mechanisms of action in major depressive disorder
    Montgomery, S.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 309 - 309
  • [3] The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action
    Amidfar, Meysam
    Reus, Gislaine Z.
    Quevedo, Joao
    Kim, Yong-Ku
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 827 : 103 - 111
  • [4] The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.
    Agrawal, Manish
    Thambi, Paul M.
    Shnayder, Sarah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD)
    Agrawal, Manish
    Shnayder, Sarah
    Honstein, Heather
    Emanuel, Ezekiel J.
    Thambi, Paul M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials
    Wang, Sheng-Min
    Kim, Sunghwan
    Choi, Won-Seok
    Lim, Hyun Kook
    Woo, Young Sup
    Pae, Chi-Un
    Bahk, Won-Myong
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (02) : 222 - 231
  • [7] Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults- A Systematic Review
    Watford, Tessa
    Masood, Naqash
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (01) : 2 - 12
  • [8] Psilocybin-Assisted Therapy for Major Depressive Disorder
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2457 - 2457
  • [9] Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
    De Diego-Adelino, Javier
    Crespo, Jose Manuel
    Mora, Fernando
    Neyra, Adrian
    Iborra, Pedro
    Gutierrez-Rojas, Luis
    Salonia, Selman F.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (05) : 673 - 690
  • [10] Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms
    Caldieraro, Marco A.
    Cassano, Paolo
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 243 : 262 - 273
12345